Publications

New research, results and findings.

Evido white paper
The price tag of a hidden global liver pandemic
August, 2023
Katrine Prier Lindvig
Taus Holtug
Maja Thiele
Aleksander Krag
Evido white paper
How to end the global liver pandemic?
January, 2023
Taus Holtug
Katrine Prier Lindvig
Maja Thiele
Aleksander Krag
Clinical and Gastroenterology and Hepatology
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
November, 2022
Maja Thiele
Aleksander Krag
Journal of The Danish Medical Association
Nonalkoholisk fedtlever-sygdom ved overvægt og metabolisk syndrom
October, 2022
Katrine Prier Lindvig
Aleksander Krag
Maja Thiele
Scandinavian Journal for Gastroenterology
Only one-third of referrals for fatty liver disease are on time: real-world study reveals opportunities to avoid unnecessary and delayed referrals
June, 2022
Katrine Prier Lindvig
Aleksander Krag
Maja Thiele
Nature, Scientific Reports
Artificial intelligence outperforms standard blood-based scores in identifying liver fibrosis patients in primary care
February, 2022
Katrine Prier Lindvig
Aleksander Krag
Maja Thiele
Journal of Hepatology
Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
November, 2021
Aleksander Krag
Maja Thiele
Scandinavian Journal of Gastroenterology
Diagnostic accuracy of routine liver function tests to identify patients with significant and advanced alcohol-related liver fibrosis
August, 2021
Katrine Prier Lindvig
News

In the press

Ingeniøren CareTech (PRO): Using existing healthcare data to remove missed diagnoses in the healthcare sector
Following our CE marking, our co-founder and CEO Taus Holtug got the opportunity to discuss his take on how we can use existing healthcare data to drive healthcare efficiency and innovations – and how our product LiverPRO fits into this.
Opinion piece
June, 2024
MedWatch: Spinout company obtain European approval for timely detection of liver disease
Evido Health kan nu sælge sin softwareløsning til tidlig opsporing af kronisk leversygdom, og timingen er perfekt, lyder det, for det første lægemiddel til sygdommen er netop blevet godkendt.
News
June, 2024
TechSavvy: Danish health tech company receives a green light from the authorities
Evido Health kan nu fortsætte udbredelsen af deres softwareløsning til påvisning af leversygdomme i Europa.
News
June, 2024
Evido obtains their first CE-certification
Evido Health secures CE certification for LiverPRO, advancing detection and management of steatotic liver disease
News
June, 2024
ISO 13485 certified
We are thrilled to announce that we have achieved ISO 13485 - Quality Management System, showing our commitment to quality and safety when developing new medical devices.
News
November, 2023
New white paper on the cost of SLD
Addressing the economic burden of SLD. Our latest white paper, exploring the economic burden of steatotic liver disease and advocating a shift towards preventive care and early detection, is now available!
White paper
September, 2023
Presented health economic at EASL 2023
In June, we attended the EASL Congress 2023 in Vienna, where we presented our health economic study comparing the cost and performance of different patient pathways. The study showed an astonishing reduction of 73% in mean cost per patient while increasing the number of correctly classified patients by 41% compared to standard of care.
Scientific conference
2023, June
Evido granted WomenTechEU
Evido has been granted €75.000 by WomenTechEU – an initiative by the European Innovation Council designed to support female founders in deep-tech startups.
News
April, 2023
BETA.HEALTH Grant Recipient: Evido
Evido has been awarded 500,000 DKK by BETA.HEALTH - an innovation platform sponsored by the Novo Nordisk Foundation.
BETA.HEALTH
January, 2023
5 million DKK granted for pilot with Nordic partner
Back in May, we kicked-off our EuroSTARS project with @Stavanger University Hospital at the top of a Norwegian ‘fjeld’. The beginning of a great partnership.
evido.news
November, 2022
Kunstig intelligens skal opdage leversygdomme i tide
Projektet LiverPRO har modtaget 500.000 fra BETA.HEALTH - The Danish national innovation platform of future healthcare, og med dem i ryggen kan forskerne bag LiverPRO implementere og markedsføre løsningen.
Odense University Hospital
July, 2022
Nyt EU-projekt tager kampen op mod skjult sygdom
Med et nyt EU-projekt skal Odense Universitetshospital (OUH), Stavanger Universitetshospital og virksomheden LT Health videreudvikle en matematisk model, som kan være med til at diagnosticere leverpatienter tidligere. Projektet med titlen LiverPRO er støttet af Eurostars med 4,2 mio. kr.
South Denmark EU office
May, 2022

We are always open for new collaborations and partnerships.

Reach out

to try our current solutions or discuss future possibilities.

About us
Publications
Contact
Cookie policy
Legal
Want to stay updated?
Sign up for our newsletter here.

All content on this website is owned by Evido ApS. You may download content only for your personal use for non-commercial purposes. No modifications or further reproduction of the content is permitted. The content may otherwise not be copied or used in any way.

The owners of this site will use reasonable efforts to include up-to-date and accurate information on this website.